Get the Stockscreener App
18.17
1.41%
-0.26
After Hours:
18.17
Innoviva Inc stock is traded at $18.17, with a volume of 608.94K.
It is down -1.41% in the last 24 hours and down -9.56% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$18.43
Open:
$18.2
24h Volume:
608.94K
Relative Volume:
0.72
Market Cap:
$1.14B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
11.01
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
-3.96%
1M Performance:
-9.56%
6M Performance:
-2.52%
1Y Performance:
-3.56%
1-Day Range:
$18.10
$18.51
1-Week Range:
$18.10
$19.01
52-Week Range:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.17 | 1.16B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
What makes Innoviva Inc. stock price move sharplySwing Trade Forecasts For Smart Trading - jammulinksnews.com
Visual trend scoring systems applied to Innoviva Inc.Free Buy Alerts With Low Risk Confirmation - Newser
How Innoviva Inc. stock performs during market volatilityFree Risk Managed Intraday Trade Alerts - Newser
Is it time to cut losses on Innoviva Inc.Short-Term Trade Setup with Forecast Insight - Newser
Is Innoviva Inc. Stock Overbought or Oversold RSI Indicator AnalysisAnnual Market Behavior and Sector Summary - Newser
Fibonacci Support Holding Strong in Innoviva Inc.Stock Market Entry Timing Signals Revealed - metal.it
Key External Factors That Drive Innoviva Inc. Stock Price MovementsCapital Growth Summary Over Five Years - Newser
Published on: 2025-07-29 06:40:52 - Newser
Innoviva (NASDAQ:INVA) shareholders are still up 34% over 5 years despite pulling back 4.9% in the past week - simplywall.st
What data driven models say about Innoviva Inc.’s futureHigh Probability Trade Plan with Indicators - Newser
What risks could impact Innoviva Inc. stock performanceFree Early Entry Picks Before News Breakout - Newser
Innoviva Inc. Rebound Backed by Sentiment ShiftAI Forecast for Trending Stocks Indicates Upside - metal.it
Screener Results Flag Innoviva Inc. as OversoldRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Relative Strength Alert For Innoviva - Nasdaq
Should I hold or sell Innoviva Inc. stock in 2025Rapid capital growth - jammulinksnews.com
What catalysts could drive Innoviva Inc. stock higher in 2025Access high-quality stock research instantly - jammulinksnews.com
Comparing Innoviva Inc. in custom built stock radarsPrice Movement and Market Sentiment Analysis - Newser
Is it time to cut losses on Innoviva Inc. Predictive Screener for Daily Trade Watch - Newser
Visual trend scoring systems applied to Innoviva Inc. Technical Long-Term Outlook and Recap Guide - Newser
Innoviva (INVA) Expected to Announce Earnings on Wednesday - Defense World
Innoviva INVA Q2 2025 Earnings Preview Upside Potential Driven by Specialty Therapeutics Growth - AInvest
What is the risk reward ratio of investing in Innoviva Inc. stockExponential wealth increase - jammulinksnews.com
What is the dividend policy of Innoviva Inc. stockRapid wealth creation - jammulinksnews.com
Is Innoviva Inc. stock overvalued or undervaluedInvest confidently with real-time updates - jammulinksnews.com
When is Innoviva Inc. stock expected to show significant growthInvest smarter with expert stock picks - jammulinksnews.com
Why is Innoviva Inc. stock attracting strong analyst attentionFree Capital Growth Strategies - jammulinksnews.com
Is Innoviva Inc. a good long term investmentTriple-digit return opportunities - PrintWeekIndia
What drives Innoviva Inc. stock priceAccelerated investment success - PrintWeekIndia
While Shareholders of Innoviva (NASDAQ:INVA) Are in the Black Over 5 Years, Those Who Bought a Week Ago Aren't so Fortunate - 富途牛牛
What analysts say about Innoviva Inc. stockTriple returns potential - PrintWeekIndia
Innoviva Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional
H.C. Wainwright Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $40 - 富途牛牛
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):